Hirokawa, Tomoko
Zou, Yixiao
Kurihara, Yuji
Jiang, Zhaoxin
Sakakibara, Yusuke
Ito, Hiromu
Funakoshi, Kengo
Kawahara, Nobutaka
Goshima, Yoshio
Strittmatter, Stephen M. http://orcid.org/0000-0001-8188-3092
Takei, Kohtaro http://orcid.org/0000-0001-6938-0812
Article History
Received: 22 November 2016
Accepted: 8 September 2017
First Online: 21 September 2017
Competing Interests
: S.M.S. is a co-founder of Axerion Therapeutics (New Haven, CT, USA), which is seeking to develop PrP- and NgR1-based therapeutics for neurological disease.